ResMed diagnostics interface makes it easy to digest most current publicly released information about ResMed as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis ResMed price relationship with some important fundamental indicators such as market cap and management efficiency.
About 65.0% of the company shares are owned by institutional investors. The company last dividend was issued on 2018-02-07. ResMed had 2:1 split on 2010-08-31. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and traded on New York Stock Exchange. It employs 6000 people. To find out more about RESMED INC contact Michael Farrell at 858-836-5000 or learn more at http://www.resmed.com.
ResMed has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
The company currently falls under 'Large-Cap' category with total capitalization of 13.8 B.
The company has Net Profit Margin of 12.98 % which may imply that it executes well on its competitive polices and has a good control over its expenditures and variable costs. This is very large. In the same way, it shows Net Operating Margin of 28.09 % which entails that for every 100 dollars of revenue it generated 0.28 of operating income.
ResMed has Return on Asset of 9.1 % which means that on every $100 spent on asset it made $9.1 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.29 % implying that it generated $15.29 on every 100 dollars invested.
ResMed holds Coefficient Of Variation of 1755.21, Semi Deviation of 1.1 and Risk Adjusted Performance of 0.091. Compared with Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of ResMed as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen technical drivers for ResMed which can be compared to its competitors. Please check ResMedInformation Ratio, Value At Risk as well as the relationship between Value At Risk and Expected Short fall to decide if ResMed is priced some-what accurately providing market reflects its current price of 96.45 per share. Given that ResMed has Jensen Alpha of 0.0669, we recommend you check out ResMed recent market performance to make sure the company can sustain itself at future point.
ResMed Price Movement Analysis
The output start index for this execution was two with a total number of output elements of thirty-seven. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ResMed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ResMed. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.